Combined effect of factor v leiden, MTHFR, and angiotensin-converting enzyme (Insertion/Deletion) gene mutations in hypertensive adult individuals: A population-based study from sivas and Canakkale, Turkey

Genetic Testing and Molecular Biomarkers

Volumn 15, Issue 11, 2011, Pages 785-791

  Demirel, Yeltekin ^a   Dogan, Sezai ^a   Uludag, Ahmet ^b   Silan, Coskun ^b   Atik, Sinem ^b   Silan, Fatma ^b   Ozdemir, Ozturk ^a,b  

^a CUMHURIYET UNIVERSITY   (Turkey)

^b ÇANAKKALE ONSEKIZ MART UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; GENE DELETION; GENE INSERTION; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; TURKEY (REPUBLIC);

ADOLESCENT; ADULT; ALLELES; CHOLESTEROL; FACTOR V; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; HYPERTENSION; INDEL MUTATION; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; TURKEY;

EID: 81755184449     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2011.0044     Document Type: Article

References (35)

1. Agaçhan B, Isbir T, Yilmaz H, Akoglu E (2003) Angiotensin converting enzyme I/D, angiotensinogen T174M-M235T and angiotensin II type 1 receptor A1166C gene polymorphisms in Turkish hypertensive patients. Exp Mol Med 35:545-549. (Pubitemid 38129319)
2. Agerholm-Larsen B, Nordestgaard BG, Tybjærg-Hansen A (2000) ACE gene polymorphism in cardiovascular disease: meta-analyses of small and large studies in Whites. Arter-ioscler Thromb Vasc Biol 20:484-492. (Pubitemid 30086107)
3. Altun B, Arici M, Nergizoglu G, et al. (2005) Prevalence, awareness, treatment and control of hypertension in Turkey (the PatenT study) in 2003. J Hypertens 23:1817-1823. (Pubitemid 41830421)
4. Bautista LE, Vargas CI, Oróstegui M, Gamarra G (2008) Population-based case-control study of renin-angiotensin system genes polymorphisms and hypertension among Hispanics. Hypertens Res 31:401-408. (Pubitemid 351597492)
5. Bersot TP, Vega GL, Grundy SM, et al. (1999) Elevated hepatic lipase activity and low levels of high density lipoprotein in a normotriglyceridemic, nonobese Turkish population. J Lipid Res 40:432-438. (Pubitemid 29116146)
6. Bhavani AB, Sastry KB, Reddy NK, Padma T (2005) Lipid profile and apolipoprotein E polymorphism in essential hypertension. Indian Heart J 57:151-157. (Pubitemid 40992666)
7. Companioni Nápoles O, Sautié Castellanos M, Leal L, et al. (2007) ACE I/D polymorphism study in a Cuban hypertensive population. Clin Chim Acta 378:112-116. (Pubitemid 46241069)
8. Conen D, Cheng S, Steiner LL, Buring JE, Ridker PM, Zee RY (2009) Association of 77 polymorphisms in 52 candidate genes with blood pressure progression and incident hypertension: the women's genome health study. J Hypertens 27:476-483.
9. Costa JSD, Barcellos FC, Sclowitz ML, et al. (2007) Hypertension prevalence and its associated risk factors in adults: a population-based study in Pelotas. Arq Bras Cardiol 88:59-65.
10. Das M, Pal S, Ghosh A (2008) Angiotensin converting enzyme gene polymorphism (insertion/deletion) and hypertension in adult Asian Indians: a population-based study from Calcutta, India. Hum Biol 80:303-312.
11. Eisenmann JC, Sarzynski MA, Glenn K, Rothschild M, Heelan KA (2009) ACE I/D genotype, adiposity, and blood pressure in children. Cardiovasc Diabetol 16:8-14.
12. Eliseeva MR, Srozhidinova NZ, Khamidullaeva GA, Abdullaeva GZh (2009) Genetic determinants of cardiovascular remodeling in Uzbek patients with essential hypertension. Ter Arkh 81:64-69.
13. Guidelines Subcommittee of the World Health Organization (1999) World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 17:151-183.
14. Halperin RO, Sesso HD, Ma J, et al. (2006) Dyslipidemia and the risk of incident hypertension in men. Hypertension 47:45-50. (Pubitemid 43177814)
15. Heux S, Morin F, Lea RA, et al. (2004) The methylenetetrahy-drofolate reductase gene variant (C677T) as a risk factor for essential hypertension in Caucasians. Hypertens Res 27:663-667. (Pubitemid 39534508)
16. Higaki J, Baba S, Katsuya T, et al. (2000) Deletion allele of an-giotensinconverting enzyme gene increases risk of essential hypertension in Japanese men: the Suita study. Circulation 101:2060-2065. (Pubitemid 30233169)
17. Jastrzebska M, Widecka K, Ciechanowicz A, et al. (2005) Plas-minogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fi-brinolytic activity in patients with essential hypertension and dyslipidemia. Pol Arch Med Wewn 113:7-20. (Pubitemid 40545543)
18. Jemaa R, Elasmi M, Naouali C, et al. (2006) Apolipoprotein E polymorphism in the Tunisian population: frequency and effect on lipid parameters. Clin Biochem 39:816-820. (Pubitemid 44201190)
19. Ayanian JZ, Zaslavsky AM, Weissman JS, Schneider EC, Gins-burg JA. (2003) Undiagnosed hypertension and hypercholes-terolemia among uninsured and insured adults in the Third National Health and Nutrition Examination Survey. Am J Pub Health 93:2051-2054. (Pubitemid 38480121)
20. Joint National Committee on Detection Evaluation and Treatment of High Blood Pressure (2003) The seventh report of the Joint National Committee on Prevention. Detection and treatment of high blood pressure (JNC VII). JAMA 289:2560-2574.
21. Kourlaba G, Pitsiladis YP, Lagou V, Grammatikaki E, Moran CN, Kondaki K, Roma-Giannikou E, Manios Y (2008) Interaction effects between total energy and macronutrient intakes and angiotensin-converting enzyme 1 (ACE) I/D polymorphism on adiposity-related phenotypes in toddlers and preschoolers: the Growth, Exercise and Nutrition Epidemiological Study in preSchoolers (GENESIS). Br J Nutr 100:1333-1340.
22. Liu C, Li H, Qi Q, Lu L, Gan W, Loos RJ, Lin X (2011) Common variants in or near FGF5, CYP17A1 and MTHFR genes are associated with blood pressure and hypertension in Chinese Hans. J Hypertens 29:70-75.
23. Lüttmann S, von Eckardstein A, Wei W, et al. (1994) Electro-phoretic screening for genetic variation in apolipoprotein C-III: Identification of a novel apoC-III variant, apoC-III Asp45(Asn), in a Turkish patient. J Lipid Res 35:1431-1440. (Pubitemid 24251038)
24. Makris TK, Krespi PG, Hatzizacharias AN, et al. (2000) Resistance to activated protein C and FV leiden mutation in patients with a history of acute myocardial infarction or primary hypertension. Am J Hypertens 13:61-65. (Pubitemid 30103865)
25. Markan S, Sachdeva M, Sehrawat BS, et al. (2007) MTHFR 677 CT/MTHFR 1298 CC genotypes are associated with increased risk of hypertension in Indians. Mol Cell Biochem 302:125-131. (Pubitemid 47202328)
26. Matsubara M, Suzuki M, Fujiwara T, et al. (2002) Angiotensin-converting enzyme I/D polymorphism and hypertension: the Ohasama study. J Hypertens 20:1121-1126. (Pubitemid 34913630)
27. Murray CJ, Lope AD (1996) Evidence-based health policy-lessons from the global burden of disease study. Science 274:740-743. (Pubitemid 26398244)
28. Nakano Y, Oshima T, Hiraga H, Matsuura H, Kajiyama G, Kambe M (1998) DD genotype of the angiotensin I-converting enzyme gene is a risk factor for early onset of essential hypertension in Japanese patients J Lab Clin Med 131:485-486.
29. Onat A (2001) Halkimiz için Total Kolesterol Düzeyi Normal Ü st Siniri Neden Mutlaka 180 mg/dl'ye Cekilmeli. Türk Kardiyol Dern Ars 29:703-707.
30. Onat A, Sansoy V, Yildirim B ve ark (1999) Eriskinlerimizde kan basinci: 8-yillik seyri, tedavi orani, koroner kalp hastaligi ile bazi etkenlerle iliskileri. Türk Kardiyoloji Dernegi Ars 27:136-143.
31. Onat A, Türkmen S, Karabulut A ve ark (2004) Türk Ye-tiskinlerinde Hiperkolesterolemi ve Hipertansiyon Birlikteligi: Sikligina ve Kardiyovaskü ler Riski Ö ngördü rmesine Iliskin TEKHARF Cxalismasi Verileri Türk Kardiyol Dern Ars 32:533-541.
32. Pamires AE, Palmero PC, Garćia LR, et al. (1999) The effect of the angiotensinogen M235T and the angiotensin-converting enzyme I/D polymorphisms on arterial hypertension and other cardiovascular risk factors. Med Clin (Barc) 113:164-168.
33. Saglam K, Yilmaz MD, Sönmez A, Baykal Y (2003) Primer Hi-pertansiyon. Nisan, Sayi 37.
34. Sesso HD, Buring JE, Chown MJ, et al. (2005) A prospective study of plasma lipid levels and hypertension in women. Arch Intern Med 165:2420-2427. (Pubitemid 41640856)
35. Yekeen LA, Sanusi RA, Ketiku AO (2003) Prevalence of obesity and high level of cholesterol in hypertension. African J Biomed Res 6:129-132.